10:07 AM EST - Antibe Therapeutics Inc. : Announces that it is extending the expiry date and amending the exercise price of the common share purchase warrants of the Company issued on August 13, 2019, June 30, 2020 and February 24, 2021. The amendments will take effect on December 29, 2023. Antibe Therapeutics Inc.
shares T.ATE are trading unchanged at $0.70.
